Tempus AI, Inc. (NASDAQ:TEM) EVP Sells $400,960.38 in Stock

Tempus AI, Inc. (NASDAQ:TEM) EVP Erik Phelps sold 5,934 shares of the business’s stock in a transaction that occurred on Wednesday, February 5th. The shares were sold at an average price of $67.57, for a total value of $400,960.38. Following the completion of the sale, the executive vice president now owns 214,662 shares of the company’s stock, valued at $14,504,711.34. The trade was a 2.69 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.

Tempus AI Stock Up 6.1 %

NASDAQ TEM opened at $68.96 on Monday. The stock’s 50 day moving average is $44.49 and its 200 day moving average is $49.16. Tempus AI, Inc. has a twelve month low of $22.89 and a twelve month high of $79.49. The company has a debt-to-equity ratio of 8.17, a quick ratio of 2.55 and a current ratio of 2.69.

Analysts Set New Price Targets

A number of equities research analysts recently commented on the stock. Guggenheim began coverage on shares of Tempus AI in a report on Monday, December 9th. They set a “buy” rating and a $74.00 price target for the company. Piper Sandler reaffirmed a “neutral” rating and set a $70.00 price objective (up from $40.00) on shares of Tempus AI in a research note on Tuesday, November 12th. TD Cowen reissued a “buy” rating and issued a $74.00 target price (up from $58.00) on shares of Tempus AI in a research note on Wednesday, February 5th. Bank of America upped their price target on Tempus AI from $52.00 to $54.00 and gave the company a “neutral” rating in a research report on Friday, December 13th. Finally, Stifel Nicolaus lowered Tempus AI from a “buy” rating to a “hold” rating and lifted their price objective for the stock from $45.00 to $65.00 in a research report on Monday, November 11th. Three investment analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. Based on data from MarketBeat.com, Tempus AI currently has an average rating of “Moderate Buy” and an average price target of $58.55.

Hedge Funds Weigh In On Tempus AI

Several institutional investors and hedge funds have recently added to or reduced their stakes in TEM. ARK Investment Management LLC increased its stake in shares of Tempus AI by 132.1% in the 4th quarter. ARK Investment Management LLC now owns 5,519,644 shares of the company’s stock worth $186,343,000 after acquiring an additional 3,141,487 shares in the last quarter. Sumitomo Mitsui Trust Group Inc. grew its holdings in Tempus AI by 166.0% in the fourth quarter. Sumitomo Mitsui Trust Group Inc. now owns 3,239,093 shares of the company’s stock worth $109,352,000 after purchasing an additional 2,021,394 shares during the period. NEA Management Company LLC increased its stake in shares of Tempus AI by 17.8% during the third quarter. NEA Management Company LLC now owns 5,385,979 shares of the company’s stock valued at $304,846,000 after purchasing an additional 813,169 shares in the last quarter. Millennium Management LLC purchased a new position in shares of Tempus AI during the second quarter valued at approximately $8,067,000. Finally, Carnegie Investment Counsel bought a new stake in shares of Tempus AI in the 3rd quarter worth approximately $7,936,000. Hedge funds and other institutional investors own 24.22% of the company’s stock.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.